Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002027832 | SCV002310252 | uncertain significance | Acrocallosal syndrome | 2023-02-10 | criteria provided, single submitter | clinical testing | This variant, c.3624_3629dup, results in the insertion of 2 amino acid(s) of the KIF7 protein (p.Gln1209_Lys1210dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752086211, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with KIF7-related conditions. ClinVar contains an entry for this variant (Variation ID: 1521247). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002548986 | SCV003526063 | uncertain significance | Inborn genetic diseases | 2020-12-19 | criteria provided, single submitter | clinical testing | The c.3624_3629dupACAGAA (p.Q1209_K1210dup) alteration is located in exon 18 (coding exon 17) of the KIF7 gene. The alteration consists of an in-frame duplication of 6 nucleotides from position 3624 to 3629, resulting in the duplication of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005008440 | SCV005640731 | uncertain significance | Acrocallosal syndrome; Multiple epiphyseal dysplasia, Al-Gazali type; Hydrolethalus syndrome 2 | 2024-04-24 | criteria provided, single submitter | clinical testing |